Meropenem Powder For Solution For Injection 1G Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Meropenem: Powder for solution for injection (1g)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MEROPENEM (mer oh PEN em) is a carbapenem antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.

In-Depth Information
Select a Medication

Meropenem 1g Powder for Injection

NDC: 007813267
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Skin And Skin Structure Infections

Sometimes used for but not FDA approved for the following conditions:
Bacteremia, Pneumonia, Peritonitis, Febrile Neutropenia, Meningitis, Intraabdominal Infections, Nosocomial Pneumonia, Appendicitis, Gram-negative Infection, Community-acquired Pneumonia

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Meropenem 1g Powder for Injection

Reported Side Effects for Meropenem 1g Powder for Injection

Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Volume Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Intestinal Blockage Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Uncontrolled Urination Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Blood Clot In Lung Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Fluid In Lungs Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Skin Ulcer Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Pelvic Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Hypoxia Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hallucinations Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Slow Heart Beat Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Drowsiness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Delirium Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Painful Urination Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Yeast Infection Incidence:
<3.1%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Heart Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
High Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Anemia Incidence:
<5.5%*
Severity: MODERATE
Onset: DELAYED
Suddenly Stopped Heart Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Low Blood Pressure Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Bowel Obstruction Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fluid Around The Lungs Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Eosinophilia Incidence:
>0.2%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
>0.2%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
0.2-2.4%*
Severity: MILD
Onset: RAPID
Low Kidney Function Incidence:
>0.2%*
Severity: SEVERE
Onset: DELAYED
Nose Bleed Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
High White Blood Cells Incidence:
>0.2%*
Severity: MILD
Onset: DELAYED
Low Potassium Levels Incidence:
>0.2%*
Severity: MODERATE
Onset: DELAYED
Melena Incidence:
0.3%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
0.5%*
Severity: SEVERE
Onset: DELAYED
Convulsions Incidence:
0.7%*
Severity: SEVERE
Onset: DELAYED
Irritated Blood Vessels Incidence:
0.8%*
Severity: MODERATE
Onset: RAPID
Upset Stomach Incidence:
0.8-7.8%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
0.8-3.6%*
Severity: MILD
Onset: EARLY
Inflamed Tongue Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Infection Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Low Blood Sugar Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Sore Throat Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.2%*
Severity: MILD
Onset: RAPID
Decreased Breathing Incidence:
1.3%*
Severity: SEVERE
Onset: DELAYED
Constipation Incidence:
1.4-7.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
1.6-1.9%*
Severity: MILD
Onset: EARLY
Headache Incidence:
2.3-7.8%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
3.5-7.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Meropenem

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5